Skip to main content

Table 4 Immunohistochemical classification in molecular subtypes of the two series

From: Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

  IBC Non-IBC  
  n (%) n (%) p value
Basal cases (ER-, ERBB2-) 24 (33.8%) 58 (15.93%) <0.001
ERBB2-overexpressing cases 24 (33.33%) 51 (14.49%) <0.001
Luminal cases (ER+, PR+) 22 (29.33%) 221 (58.93%) <0.001